<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 19:02:37 -0700</creation_date>
  <update_date>2013-01-15 19:02:37 -0700</update_date>
  <accession>HMDBP02107</accession>
  <secondary_accessions>
    <accession>7589</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>BFGF</synonym>
    <synonym>Basic fibroblast growth factor</synonym>
    <synonym>HBGF-2</synonym>
  </synonyms>
  <gene_name>FGF2</gene_name>
  <general_function>Involved in growth factor activity</general_function>
  <specific_function>The heparin-binding growth factors are angiogenic agents in vivo and are potent mitogens for a variety of cell types in vitro. There are differences in the tissue distribution and concentration of these 2 growth factors</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB01394</accession>
      <name>Heparin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14508</accession>
      <name>Sucralfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14824</accession>
      <name>Pentosan Polysulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15015</accession>
      <name>Sirolimus</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>protein binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>receptor binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>growth factor activity</description>
      <go_id/>
    </go_class>
  </go_classifications>
  <subcellular_locations>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:4</chromosome_location>
    <locus>4q26</locus>
    <gene_sequence>&gt;867 bp
CTGGTGGGTGTGGGGGGTGGAGATGTAGAAGATGTGACGCCGCGGCCCGGCGGGTGCCAG
ATTAGCGGACGCGGTGCCCGCGGTTGCAACGGGATCCCGGGCGCTGCAGCTTGGGAGGCG
GCTCTCCCCAGGCGGCGTCCGCGGAGACACCCATCCGTGAACCCCAGGTCCCGGGCCGCC
GGCTCGCCGCGCACCAGGGGCCGGCGGACAGAAGAGCGGCCGAGCGGCTCGAGGCTGGGG
GACCGCGGGCGCGGCCGCGCGCTGCCGGGCGGGAGGCTGGGGGGCCGGGGCCGGGGCCGT
GCCCCGGAGCGGGTCGGAGGCCGGGGCCGGGGCCGGGGGACGGCGGCTCCCCGCGCGGCT
CCAGCGGCTCGGGGATCCCGGCCGGGCCCCGCAGGGACCATGGCAGCCGGGAGCATCACC
ACGCTGCCCGCCTTGCCCGAGGATGGCGGCAGCGGCGCCTTCCCGCCCGGCCACTTCAAG
GACCCCAAGCGGCTGTACTGCAAAAACGGGGGCTTCTTCCTGCGCATCCACCCCGACGGC
CGAGTTGACGGGGTCCGGGAGAAGAGCGACCCTCACATCAAGCTACAACTTCAAGCAGAA
GAGAGAGGAGTTGTGTCTATCAAAGGAGTGTGTGCTAACCGTTACCTGGCTATGAAGGAA
GATGGAAGATTACTGGCTTCTAAATGTGTTACGGATGAGTGTTTCTTTTTTGAACGATTG
GAATCTAATAACTACAATACTTACCGGTCAAGGAAATACACCAGTTGGTATGTGGCACTG
AAACGAACTGGGCAGTATAAACTTGGATCCAAAACAGGACCTGGGCAGAAAGCTATACTT
TTTCTTCCAATGTCTGCTAAGAGCTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>288</residue_number>
    <molecular_weight>30769.7</molecular_weight>
    <theoretical_pi>11.71</theoretical_pi>
    <pfams>
      <pfam>
        <name>FGF</name>
        <pfam_id>PF00167</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
      <region>None</region>
    </transmembrane_regions>
    <signal_regions>
      <region>None</region>
    </signal_regions>
    <protein_sequence>&gt;Heparin-binding growth factor 2
MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVNPRSRAA
GSPRTRGRRTEERPSGSRLGDRGRGRALPGGRLGGRGRGRAPERVGGRGRGRGTAAPRAA
PAARGSRPGPAGTMAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDG
RVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERL
ESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS</protein_sequence>
  </protein_properties>
  <genbank_protein_id>153285461</genbank_protein_id>
  <uniprot_id>P09038</uniprot_id>
  <uniprot_name>FGF2_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1IIL</pdb_id>
  </pdb_ids>
  <genbank_gene_id>NM_002006.4</genbank_gene_id>
  <genecard_id>FGF2</genecard_id>
  <geneatlas_id>FGF2</geneatlas_id>
  <hgnc_id>HGNC:3676</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Abraham JA, Whang JL, Tumolo A, Mergia A, Fiddes JC: Human basic fibroblast growth factor: nucleotide sequence, genomic organization, and expression in mammalian cells. Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:657-68.</reference_text>
      <pubmed_id>3472745</pubmed_id>
    </reference>
    <reference>
      <reference_text>Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC: Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 1986 Oct;5(10):2523-8.</reference_text>
      <pubmed_id>3780670</pubmed_id>
    </reference>
    <reference>
      <reference_text>Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, et al.: High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1836-40.</reference_text>
      <pubmed_id>2538817</pubmed_id>
    </reference>
    <reference>
      <reference_text>Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H, Yanagisawa Y, Endo Y, Imamoto F, Kisu Y, Tanaka S, Isogai T, Imai J, Watanabe S, Nomura N: Human protein factory for converting the transcriptome into an in vitro-expressed proteome,. Nat Methods. 2008 Dec;5(12):1011-7.</reference_text>
      <pubmed_id>19054851</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.</reference_text>
      <pubmed_id>15815621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Florkiewicz RZ, Shibata F, Barankiewicz T, Baird A, Gonzalez AM, Florkiewicz E, Shah N: Basic fibroblast growth factor gene expression.  Ann N Y Acad Sci. 1991;638:109-26.</reference_text>
      <pubmed_id>1785797</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kurokawa T, Sasada R, Iwane M, Igarashi K: Cloning and expression of cDNA encoding human basic fibroblast growth factor. FEBS Lett. 1987 Mar 9;213(1):189-94.</reference_text>
      <pubmed_id>2435575</pubmed_id>
    </reference>
    <reference>
      <reference_text>Shimoyama Y, Gotoh M, Ino Y, Sakamoto M, Kato K, Hirohashi S: Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis. Jpn J Cancer Res. 1991 Nov;82(11):1263-70.</reference_text>
      <pubmed_id>1721615</pubmed_id>
    </reference>
    <reference>
      <reference_text>Izbicka E, Dunstan C, Esparza J, Jacobs C, Sabatini M, Mundy GR: Human amniotic tumor that induces new bone formation in vivo produces growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor. Cancer Res. 1996 Feb 1;56(3):633-6.</reference_text>
      <pubmed_id>8564983</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sommer A, Brewer MT, Thompson RC, Moscatelli D, Presta M, Rifkin DB: A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun. 1987 Apr 29;144(2):543-50.</reference_text>
      <pubmed_id>3579930</pubmed_id>
    </reference>
    <reference>
      <reference_text>Story MT, Esch F, Shimasaki S, Sasse J, Jacobs SC, Lawson RK: Amino-terminal sequence of a large form of basic fibroblast growth factor isolated from human benign prostatic hyperplastic tissue. Biochem Biophys Res Commun. 1987 Feb 13;142(3):702-9.</reference_text>
      <pubmed_id>2435284</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA: Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. Biochem Biophys Res Commun. 1986 Mar 13;135(2):541-8.</reference_text>
      <pubmed_id>3964259</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gautschi P, Frater-Schroder M, Bohlen P: Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors. FEBS Lett. 1986 Aug 18;204(2):203-7.</reference_text>
      <pubmed_id>3732516</pubmed_id>
    </reference>
    <reference>
      <reference_text>Watson R, Anthony F, Pickett M, Lambden P, Masson GM, Thomas EJ: Reverse transcription with nested polymerase chain reaction shows expression of basic fibroblast growth factor transcripts in human granulosa and cumulus cells from in vitro fertilisation patients. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1227-31.</reference_text>
      <pubmed_id>1417798</pubmed_id>
    </reference>
    <reference>
      <reference_text>Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD: Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem. 1991 Sep 5;266(25):16778-85.</reference_text>
      <pubmed_id>1885605</pubmed_id>
    </reference>
    <reference>
      <reference_text>Goretzki L, Burg MA, Grako KA, Stallcup WB: High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem. 1999 Jun 11;274(24):16831-7.</reference_text>
      <pubmed_id>10358027</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tassi E, Al-Attar A, Aigner A, Swift MR, McDonnell K, Karavanov A, Wellstein A: Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J Biol Chem. 2001 Oct 26;276(43):40247-53. Epub 2001 Aug 16.</reference_text>
      <pubmed_id>11509569</pubmed_id>
    </reference>
    <reference>
      <reference_text>Xie B, Tassi E, Swift MR, McDonnell K, Bowden ET, Wang S, Ueda Y, Tomita Y, Riegel AT, Wellstein A: Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J Biol Chem. 2006 Jan 13;281(2):1137-44. Epub 2005 Oct 27.</reference_text>
      <pubmed_id>16257968</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ago H, Kitagawa Y, Fujishima A, Matsuura Y, Katsube Y: Crystal structure of basic fibroblast growth factor at 1.6 A resolution.  J Biochem (Tokyo). 1991 Sep;110(3):360-3.</reference_text>
      <pubmed_id>1769963</pubmed_id>
    </reference>
    <reference>
      <reference_text>Eriksson AE, Cousens LS, Weaver LH, Matthews BW: Three-dimensional structure of human basic fibroblast growth factor.  Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3441-5.</reference_text>
      <pubmed_id>1707542</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang JD, Cousens LS, Barr PJ, Sprang SR: Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3446-50.</reference_text>
      <pubmed_id>1849658</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhu X, Komiya H, Chirino A, Faham S, Fox GM, Arakawa T, Hsu BT, Rees DC: Three-dimensional structures of acidic and basic fibroblast growth factors. Science. 1991 Jan 4;251(4989):90-3.</reference_text>
      <pubmed_id>1702556</pubmed_id>
    </reference>
    <reference>
      <reference_text>Eriksson AE, Cousens LS, Matthews BW: Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution. Protein Sci. 1993 Aug;2(8):1274-84.</reference_text>
      <pubmed_id>7691311</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M: Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7182-7. Epub 2001 Jun 5.</reference_text>
      <pubmed_id>11390973</pubmed_id>
    </reference>
    <reference>
      <reference_text>Moy FJ, Seddon AP, Bohlen P, Powers R: High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry. 1996 Oct 22;35(42):13552-61.</reference_text>
      <pubmed_id>8885834</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Sucralfate</name>
        <accession>HMDB14508</accession>
      </metabolite>
      <reference>
        <reference_text>Szabo S: The mode of action of sucralfate: the 1 x 1 x 1 mechanism of action.  Scand J Gastroenterol Suppl. 1991;185:7-12.</reference_text>
        <pubmed_id>1957124</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sucralfate</name>
        <accession>HMDB14508</accession>
      </metabolite>
      <reference>
        <reference_text>Tarnawski A, Tanoue K, Santos AM, Sarfeh IJ: Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment? Scand J Gastroenterol Suppl. 1995;210:9-14.</reference_text>
        <pubmed_id>8578218</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sucralfate</name>
        <accession>HMDB14508</accession>
      </metabolite>
      <reference>
        <reference_text>Szabo S, Kusstatscher S, Sakoulas G, Sandor Z, Vincze A, Jadus M: Growth factors: new 'endogenous drugs' for ulcer healing.  Scand J Gastroenterol Suppl. 1995;210:15-8.</reference_text>
        <pubmed_id>8578198</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sucralfate</name>
        <accession>HMDB14508</accession>
      </metabolite>
      <reference>
        <reference_text>Konturek SJ: Role of growth factors in gastroduodenal protection and healing of peptic ulcers.  Gastroenterol Clin North Am. 1990 Mar;19(1):41-65.</reference_text>
        <pubmed_id>1970337</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sucralfate</name>
        <accession>HMDB14508</accession>
      </metabolite>
      <reference>
        <reference_text>Korman MG, Bolin TD, Szabo S, Hunt RH, Marks IN, Glise H: Sucralfate: the Bangkok review.  J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):412-5.</reference_text>
        <pubmed_id>7948825</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pentosan Polysulfate</name>
        <accession>HMDB14824</accession>
      </metabolite>
      <reference>
        <reference_text>Zugmaier G, Favoni R, Jaeger R, Rosen N, Knabbe C: Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors. Ann N Y Acad Sci. 1999;886:243-8.</reference_text>
        <pubmed_id>10667230</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pentosan Polysulfate</name>
        <accession>HMDB14824</accession>
      </metabolite>
      <reference>
        <reference_text>Mucha S, Melen-Mucha G, Stepien T, Godlewski A, Stepien H: Effects of pentosan polysulfate sodium on the estrogen-induced pituitary prolactinoma in Fischer 344 rats. Oncol Rep. 2002 Nov-Dec;9(6):1385-9.</reference_text>
        <pubmed_id>12375053</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pentosan Polysulfate</name>
        <accession>HMDB14824</accession>
      </metabolite>
      <reference>
        <reference_text>Pluda JM, Shay LE, Foli A, Tannenbaum S, Cohen PJ, Goldspiel BR, Adamo D, Cooper MR, Broder S, Yarchoan R: Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst. 1993 Oct 6;85(19):1585-92.</reference_text>
        <pubmed_id>7692072</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pentosan Polysulfate</name>
        <accession>HMDB14824</accession>
      </metabolite>
      <reference>
        <reference_text>McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis. Breast Cancer Res Treat. 1996;39(1):103-17.</reference_text>
        <pubmed_id>8738610</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pentosan Polysulfate</name>
        <accession>HMDB14824</accession>
      </metabolite>
      <reference>
        <reference_text>Jerebtsova M, Wong E, Przygodzki R, Tang P, Ray PE: A novel role of fibroblast growth factor-2 and pentosan polysulfate in the pathogenesis of intestinal bleeding in mice. Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H743-50. Epub 2006 Oct 27.</reference_text>
        <pubmed_id>17071728</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sirolimus</name>
        <accession>HMDB15015</accession>
      </metabolite>
      <reference>
        <reference_text>Sehgal SN: Sirolimus: its discovery, biological properties, and mechanism of action.  Transplant Proc. 2003 May;35(3 Suppl):7S-14S.</reference_text>
        <pubmed_id>12742462</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
